Difference in serotonergic and noradrenergic regulation of human social behaviours

Psychopharmacology

Volumn 159, Issue 2, 2002, Pages 216-221

  Tse, Wai S ^a   Bond, Alyson J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Non verbal behaviour; Noradrenaline; Serotonin; Social drive

Indexed keywords

CITALOPRAM; NORADRENALIN; REBOXETINE; SEROTONIN;

ARTICLE; CONTROLLED STUDY; COOPERATION; DRUG EFFECT; FEMALE; GAME; HUMAN; HUMAN EXPERIMENT; INTERPERSONAL COMMUNICATION; MALE; MOOD; NORADRENERGIC SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; READING; REGULATORY MECHANISM; SEROTONINERGIC SYSTEM; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TASK PERFORMANCE;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ANALYSIS OF VARIANCE; CITALOPRAM; COOPERATIVE BEHAVIOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MORPHOLINES; NOREPINEPHRINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR; SPEECH;

EID: 0036166806     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-001-0926-9     Document Type: Article

References (29)

1. Psychometric properties of the Beck depression inventory: 25 Years of evaluation
2. Development and validation of a social functioning scale, the social adaptation self-evaluation scale
3. A longitudinal study of interaction patterns of a psychiatrist and severely depressed patients based on observed behaviours: An ethological approach of interpersonal theories of depression
4. Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation
5. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects
6. The neuropsychopharmacology of personality disorders
7. Depression and the response of others
8. Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor
9. Do noradrenaline and serotonin differentially affect social motivation and behaviour?
10. The ethological approach to the assessment of depressive disorders
11. Do alpha 2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?
12. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: Activation of serotonin 1A receptors and blockade of alpha2-adrenergic receptors underlie its actions
13. The enhancement of social functioning as a therapeutic principle in the management of depression
14. Reboxetine, a selective noradrenaline reuptake inhibitor, is non-sedative and does not impair psychomotor performance in healthy subjects
15. Interpersonal behavior in depressive individuals in a mixed-motive game
16. Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex
17. Selective alteration of personality and social behavior by serotonergic intervention
18. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients
19. Reboxetine: A double-blind comparison with fluoxetine in major depressive disorder
20. Aggression, anxiety and vocalizations in animals: GABAa and 5-HT anxiolytics
21. Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous puillary fluctuations in healthy human volunteers
22. Differential behavioral effects of tryptophan and 5-hydroxytryptophan in vervet monkeys: Influence of catecholaminergic systems
23. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: Implication of noradrenergic and serotonergic mechanisms
24. Attributions as moderators of affective and behavioral responses to social failure
25. Fluency changes in persons who stutter following a double blind trial of clomipramine and desipramine
26. The speech analysis approach to determining onset of improvement under antidepressants
27. Development and validation of brief measures of positive and negative affect: The PANAS scales
28. Social functioning and the treatment of depression